Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  Fleming, Ingrid ^a   Busse, Rudi ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Calmodulin; Caveolin; mRNA stability; Phosphatase; Serine phosphorylation; Threonine phosphorylation

Indexed keywords

ADENYLATE KINASE; CALCINEURIN INHIBITOR; CALCIUM ION; CAVEOLIN 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN A; DYNAMIN; G PROTEIN COUPLED RECEPTOR; HEAT SHOCK PROTEIN 90; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE B; SERINE; TACROLIMUS;

BLOOD FLOW; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037216768     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00323.2002     Document Type: Review

References (137)

1. Andries LJ, Brutsaert DL, and Sys SU. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res 82: 195-203, 1998.
2. Arnal JF, Yamin J, Dockery S, and Harrison DG. Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am J Physiol Cell Physiol 267: C1381-C1388, 1994.
3. Arriero MM, de la Pinta JC, Escribano M, Celdran A, Munoz-Alameda L, Garcia-Canete J, Jimenez AM, Casado S, Farre J, and Lopez-Farre A. Aspirin prevents Escherichia coli lipopolysaccharide- and Staphylococcus aureus-induced downregulation of endothelial nitric oxide synthase expression in guinea pig pericardial tissue. Circ Res 90: 719-727, 2002.
4. Ayajiki K, Kindermann M, Hecker M, Fleming I, and Busse R. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res 78: 750-758, 1996.
5. Bauersachs J, Fleming I, Scholz D, Popp R, and Busse R. Endothelium-derived hyperpolarizing factor but not nitric oxide is reversibly inhibited by brefeldin A. Hypertension 30: 1598-1605, 1997.
6. 2 kinin receptor within the plasma membrane of native endothelial cells. Circulation 99: 2034-2040, 1999.
7. Bernier SG, Haldar S, and Michel T. Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem 275: 30707-30715, 2000.
8. Billecke SS, Bender AT, Kanelakis KC, Murphy PJ, Lowe ER, Kamada Y, Pratt WB, and Osawa Y. HSP90 is required for heme binding and activation of APO-neuronal nitric-oxide synthase: Geldanamycin-mediated oxidant generation is unrelated to any action of HSP90. J Biol Chem 277: 20504-20509, 2002.
9. 1179 by Akt-independent mechanisms: Role of protein kinase A. J Biol Chem 277: 3388-3396, 2002.
10. Brophy CM, Woodrum DA, Pollock J, Dickinson M, Komalavilas P, Cornwell TL, and Lincoln TM. cGMP-dependent protein kinase expression restores contractile function in cultured vascular smooth muscle cells. J Vasc Res 39: 95-103, 2002.
11. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, and Sessa WC. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6: 1362-1367, 2000.
12. Busconi L and Michel T. Endothelial nitric oxide synthase: N-terminal myristoylation determines subcellular localization. J Biol Chem 268: 8410-8413, 1993.
13. Busse R and Mülsch A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett 265: 133-136, 1990.
14. Butt E, Bernhardt M, Smolenski A, Kotsonis P, Frohlich LG, Sickmann A, Meyer HE, Lohmann SM, and Schmidt HHHW. Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem 275: 5179-5187, 2000.
15. 2+/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol 21: 1571-1576, 2001.
16. Cao S, Yao J, Mccabe TJ, Yao Q, Katusic ZS, Sessa WC, and Shah V. Direct interaction between endothelial nitricoxide synthase and dynamin-2. Implications for nitric-oxide synthase function. J Biol Chem 276: 14249-14256, 2001.
17. Caplan AJ. Hsp90's secrets unfold: New insights from structural and functional studies. Trends Cell Biol 9: 262-268, 1999.
18. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, and Shaul PW. Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87: E44-E52, 2000.
19. Chen ZP, Mitchelhill KI, Michell BJ, Stapelton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, and Kemp BE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443: 285-289, 1999.
20. Cieslik K, Zembowicz A, Tang JL, and Wu KK. Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J Biol Chem 273: 14885-14890, 1998.
21. Cordelier P, Esteve JP, Rivard N, Marletta M, Vaysse N, Susini C, and Buscail L. The activation of neuronal NO synthase is mediated by G-protein βγ subunit and the tyrosine phosphatase SHP-2. FASEB J 13: 2037-2050, 1999.
22. Corson MA, James NL, Latta SE, Nerem RM, Berk BC, and Harrison DG. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 79: 984-991, 1996.
23. Danino D and Hinshaw JE. Dynamin family of mechanoenzymes. Curr Opin Cell Biol 13: 454-460, 2001.
24. Davda RK, Chandler LJ, and Guzman NJ. Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase. Eur J Pharmacol 266: 237-244, 1994.
25. Dedio J, Konig P, Wohlfart P, Schroeder C, Kummer W, and Müller-Esterl W. NOSIP, a novel modulator of endothelial nitric oxide synthase activity. FASEB J 15: 79-89, 2001.
26. Dessy C, Kelly RA, Balligand JL, and Feron O. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J 19: 4272-4280, 2000.
27. Dikalov S, Landmesser U, and Harrison DG. Geldanamycin leads to superoxide formation by enzymatic and non-enzymatic redox cycling: Implications for studies of Hsp90 and eNOS. J Biol Chem 277: 25480-25485, 2002.
28. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
29. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, and Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
30. Drummond GR, Cai H, Davis ME, Ramasamy S, and Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86: 347-354, 2000.
31. Feng Y, Venema VJ, Venema RC, Tsai N, and Caldwell RB. VEGF induces nuclear translocation of Flk-1/KDR, endothleial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun 256: 192-197, 1999.
32. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, and Michel T. Endothelial nitric oxide synthase targeting to caveolae-specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271: 22810-22814, 1996.
33. Fisslthaler B, Dimmeler S, Hermann C, Busse R, and Fleming I. Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress. Acta Physiol Scand 168: 81-88, 2000.
34. Fleming I, Bara A, and Busse R. Calcium signalling and autacoid production in endothelial cells are modulated by changes in tyrosine kinase and phosphatase activity. J Vasc Res 33: 225-234, 1996.
35. 2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res 82: 686-695, 1998.
36. 2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88: e68-e75, 2001.
37. Fontana J, Fulton D, Chen Y, Fairchild TA, Mccabe TJ, Fujita N, Tsuruo T, and Sessa WC. Domain mapping studies reveal that the M domain of Hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 90: 866-873, 2002.
38. Forget G, Siminovitch KA, Brochu S, Rivest S, Radzioch D, and Olivier M. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur J Immunol 31: 3185-3196, 2001.
39. Förstermann U, Boissel JP, and Kleinert H. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12: 773-790, 1998.
40. Fulton D, Fontana J, Sowa G, Gratton JP, Lin M, Li KX, Michell B, Kemp BE, Rodman D, and Sessa WC. Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J Biol Chem 277: 4277-4284, 2002.
41. Fulton D, Gratton JP, Mccabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
42. Fulton D, Gratton JP, and Sessa WC. Posttranslational control of endothelial nitric oxide synthase: Why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 299: 818-824, 2001.
43. Gallis B, Corthals GL, Goodlett DR, Ueba H, Kim F, Presnell SR, Figeys D, Harrison DG, Berk BC, Aebersold R, and Corson MA. Identification of flow-dependent endothelial nitric oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem 274: 30101-30108, 1999.
44. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, and Sessa WC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453, 1996.
45. García-Cardena G, Fan G, Stern DF, Liu J, and Sessa WC. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem 271: 27237-27240, 1996.
46. García-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, and Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 292: 821-824, 1998.
47. García-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li SW, Lisanti MP, and Sessa WC. Dissecting the interaction between nitric oxide synthase (NOS) and caveolinfunctional significance of the NOS caveolin binding domain in vivo. J Biol Chem 272: 25437-25440, 1997.
48. German Z, Chambliss KL, Pace MC, Arnet UA, Lowenstein CJ, and Shaul PW. Molecular basis of cell-specific endothelial nitric-oxide synthase expression in airway epithelium. J Biol Chem 275: 8183-8189, 2000.
49. Ghosh S, Gachhui R, Crooks C, Wu CQ, Lisanti MP, and Stuehr DJ. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase-consequences for catalysis. J Biol Chem 273: 22267-22271, 1998.
50. Giordano A, Tonello C, Bulbarelli A, Cozzi V, Cinti S, Carruba MO, and Nisoli E. Evidence for a functional nitric oxide synthase system in brown adipocyte nucleus. FEBS Lett 514: 135-140, 2002.
51. Go YM, Park H, Maland MC, Darley-Usmar VM, Stoyanov B, Wetzker R, and Jo H. Phosphatidylinositol 3-kinase gamma mediates shear stress-dependent activation of JNK in endothelial cells. Am J Physiol Heart Circ Physiol 275: H1898-H1904, 1998.
52. Goetz RM, Thatte HS, Prabhakar P, Cho MR, Michel T, and Golan DE. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 96: 2788-2793, 1999.
53. Golser R, Gorren ACF, Leber A, Andrew P, Habisch HJ, Werner ER, Schmidt K, Venema RC, and Mayer B. Interaction of endothelial and neuronal nitric-OXIDE synthases with the bradykinin B2 receptor. Binding of an inhibitory peptide to the oxygenase domain blocks uncoupled NADPH oxidation. J Biol Chem 275: 5291-5296, 2000.
54. Gonzalez-Fernandez F, Jimenez A, Lopez-Blaya A, Velasco S, Arriero MM, Celdran A, Rico L, Farre J, Casado S, and Lopez-Farre A. Cerivastatin prevents tumor necrosis factor-alpha-induced downregulation of endothelial nitric oxide synthase: Role of endothelial cytosolic proteins. Atherosclerosis 155: 61-70, 2001.
55. Govers R, Bevers L, de Bree P, and Rabelink TJ. Endothelial nitric oxide synthase activity is linked to its presence at cell-cell contacts. Biochem J 361: 193-201, 2002.
56. Govers R, Van Der SP, Van Donselaar E, Slot JW, and Rabelink TJ. Endothelial nitric oxide synthase and its negative regulator caveolin-1 localize to distinct perinuclear organelles. J Histochem Cytochem 50: 779-788, 2002.
57. Gratton JP, Fontana J, O'Connor DS, Garcia-Cardena G, Mccabe TJ, and Sessa WC. Reconstitution of an endothelial nitric oxide synthase, Hsp90 and caveolin-1 complex in vitro: Evidence that Hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem 275: 22268-22272, 2000.
58. Harris MB, Ju H, Venema VJ, Blackstone M, and Venema RC. Role of heat shock protein 90 in bradykinin-stimulated endothelial nitric oxide release. Gen Pharmacol 35: 165-170, 2000.
59. Harris MB, Ju H, Venema VJ, Liang H, Zou R, Michell BJ, Chen ZP, Kemp BE, and Venema RC. Reciprocal phosphorylation and regulation of the endothelial nitric oxide synthase in response to bradykinin stimulation (Abstract). J Biol Chem 19: 16587-16591, 2001.
60. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, and Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87: 677-682, 2000.
61. Hecker M, Mulsch A, Bassenge E, Forstermann U, and Busse R. Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: Physiological implications. Biochem J 299: 247-252, 1994.
62. Hellermann GR, Flam BR, Eichler DC, and Solomonson LP. Stimulation of receptor-mediated nitric oxide production by vanadate. Arterioscler Thromb Vasc Biol 20: 2045-2050, 2000.
63. Hinshaw JE. Dynamin and its role in membrane fission. Annu Rev Cell Dev Biol 16: 483-519, 2000.
64. Hirata K, Kuroda R, Sakoda T, Katayama M, Inoue N, Suematsu M, Kawashima S, and Yokoyama M. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25: 180-185, 1995.
65. 2+ oscillations and STOC activation in endothelial cells. FASEB J 12: 359-366, 1998.
66. Jayachandran M, Hayashi T, Sumi D, Iguchi A, and Miller VM. Temporal effects of 17β-estradiol on caveolin-1 mRNA and protein in bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 281: H1327-H1333, 2001.
67. Jimenez A, Arriero MM, Lopez-Blaya A, Gonzalez-Fernandez F, Garcia R, Fortes J, Millas I, Velasco S, Sanchez DM, Rico L, Farre J, Casado S, and Lopez-Farre A. Regulation of endothelial nitric oxide synthase expression in the vascular wall and in mononuclear cells from hypercholesterolemic rabbits. Circulation 104: 1822-1830, 2001.
68. 2 receptor with endothelial nitric oxide synthase. J Biol Chem 273: 24025-24029, 1998.
69. Ju H, Zou R, Venema VJ, and Venema RC. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 272: 18522-18525, 1997.
70. Kammerl MC, Richthammer W, Kurtz A, and Kramer BK. Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression. Am J Physiol Regul Integr Comp Physiol 282: R1613-R1617, 2002.
71. Kanai AJ, Strauss HC, Truskey GA, Crews AL, Grunfeld S, and Malinski T. Shear stress induces ATP-independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor. Circ Res 77: 284-293, 1995.
72. Karantzoulis-Fegaras F, Antoniou H, Lai SL, Kulkarni G, D'Abreo C, Wong GK, Miller TL, Chan Y, Atkins J, Wang Y, and Marsden PA. Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 274: 3076-3093, 1999.
73. Kim F, Gallis B, and Corson MA. TNF-α inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Am J Physiol Cell Physiol 280: C1057-C1065, 2001.
74. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, and Förstermann U. Estrogens increase transcription of the human endothelial NO synthase gene: Analysis of the transcription factors involved. Hypertension 31: 582-588, 1998.
75. Kou R, Prabhakar P, and Michel T. Phosphorylation of the endothelial isoform of nitric oxide synthase at serine 116: Identification of a novel path for eNOS regulation by lysophosphatidic acid. Circulation 104: 509, 2001.
76. Lantinhermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, and Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol Lung Cell Mol Physiol 273: L119-L126, 1997.
77. Laufs U, La F V, Plutzky J, and Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135, 1998.
78. Laumonnier Y, Nadaud S, Agrapart M, and Soubrier F. Characterization of an upstream enhancer region in the promoter of the human endothelial nitric-oxide synthase gene. J Biol Chem 275: 40732-40741, 2000.
79. Li H, Brodsky S, Basco M, Romanov V, De Angelis DA, and Goligorsky MS. Nitric oxide attenuates signal transduction: Possible role in dissociating caveolin-1 scaffold. Circ Res 88: 229-236, 2001.
80. Lincoln TM, Dey N, and Sellak H. Signal transduction in smooth muscle: Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: From the regulation of tone to gene expression. J Appl Physiol 91: 1421-1430, 2001.
81. Liu J, García-Cardena G, and Sessa WC. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: mutagenesis of palmitoylation sites, cysteines-15 and/or -26, argues against depalmitoylation-induced translocation of the enzyme. Biochemistry 34: 12333-12340, 1995.
82. Liu J, García-Cardena G, and Sessa WC. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: Implications for caveolae localization. Biochemistry 35: 13277-13281, 1996.
83. Liu J, Hughes TE, and Sessa WC. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: A green fluorescent protein study. J Cell Biol 137: 1525-1535, 1997.
84. Lopez F, Ferjoux G, Cordelier P, Saint-Laurent N, Esteve JP, Vaysse N, Buscail L, and Susini C. Neuronal nitric oxide synthase: A substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling. FASEB J 15: 2300-2302, 2001.
85. Luckhoff A, Pohl U, Mulsch A, and Busse R. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Br J Pharmacol 95: 189-196, 1988.
86. Macritchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS, and Shaul PW. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 81: 355-362, 1997.
87. Marrero MB, Venema VJ, Ju H, He H, Liang H, Caldwell RB, and Venema RC. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J 343: 335-340, 1999.
88. Martinez-Gonzalez J, Raposo B, Rodriguez C, and Badimon L. 3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: Balance between transcriptional and posttranscriptional regulation. Arterioscler Thromb Vasc Biol 21: 804-809, 2001.
89. 2+-calmodulin. Biochemistry 35: 14651-14658, 1996.
90. Mccabe TJ, Fulton D, Roman LJ, and Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J Biol Chem 275: 6123-6128, 2000.
91. McNeill AM, Kim N, Duckles SP, Krause DN, and Kontos HA. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30: 2186-2190, 1999.
92. McQuillan LP, Leung GK, Marsden PA, Kostyk SK, and Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol Heart Circ Physiol 267: H1921-H1927, 1994.
93. 2+-calmodulin and caveolin. J Biol Chem 272: 15583-15586, 1997.
94. Michel T, Li GK, and Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 90: 6252-6256, 1993.
95. Michell BJ, Chen Z, Tiganis T, Stapelton D, Katsis F, Power DA, Sim AT, and Kemp BE. Coordinated control of endothelial NO synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276: 17625-17628, 2001.
96. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M, Harada M, Kajiyama N, Kishimoto I, Kuwahara K, Hino J, Ogawa E, Hamanaka I, Kamitani S, Takahashi N, Kawakami R, Kangawa K, Yasue H, and Nakao K. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T→C mutation associated with coronary spastic angina. Hum Mol Genet 9: 2629-2637, 2000.
97. Mohamed F, Monge JC, Gordon A, Cernacek P, Blais D, and Stewart DJ. Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 15: 52-57, 1995.
98. Moreno C, Lopez A, Llinas MT, Rodriguez F, Lopez-Farre A, Nava E, and Salazar FJ. Changes in NOS activity and protein expression during acute and prolonged ANG II administration. Am J Physiol Regul Integr Comp Physiol 282: R31-R37, 2002.
99. O'Brien AJ, Young HM, Povey JM, and Furness JB. Nitric oxide synthase is localized predominantly in the Golgi apparatus and cytoplasmic vesicles of vascular endothelial cells. Histochemistry 103: 221-225, 1995.
100. Pelligrino DA, Ye S, Tan F, Santizo RA, Feinstein DL, and Wang Q. Nitric-oxide-dependent pial arteriolar dilation in the female rat: Effects of chronic estrogen depletion and repletion. Biochem Biophys Res Commun 269: 165-171, 2000.
101. Prabhakar P, Thatte HS, Goetz RM, Cho MR, Golan DE, and Michel T. Receptor-regulated translocation of endothelial nitric oxide synthase. J Biol Chem 273: 27383-27388, 1998.
102. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, and Sessa WC. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 276: 17621-17624, 2001.
103. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, and Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
104. Rembold CM, Foster DB, Strauss JD, Wingard CJ, and Eyk JE. cGMP-mediated phosphorylation of heat shock protein 20 may cause smooth muscle relaxation without myosin light chain dephosphorylation in swine carotid artery. J Physiol 524: 865-878, 2000.
105. Rembold CM, O'Connor M, Clarkson M, Wardle RL, and Murphy RA. Selected contribution: HSP20 phosphorylation in nitroglycerin- and forskolin-induced sustained reductions in swine carotid media tone. J Appl Physiol 91: 1460-1466, 2001.
106. Robinson LJ, Busconi L, and Michel T. Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem 270: 995-998, 1995.
107. Rupnow HL, Phernetton TM, Shaw CE, Modrick ML, Bird IM, and Magness RR. Endothelial vasodilator production by uterine and systemic arteries. VII Estrogen and progesterone effects on eNOS. Am J Physiol Heart Circ Physiol 280: H1699-H1705, 2001.
108. Russell KS, Haynes MP, Caulin-Glaser T, Rosneck J, Sessa WC, and Bender JR. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J Biol Chem 275: 5026-5030, 2000.
109. Sakoda T, Hirata K, Kuroda R, Miki N, Suematsu M, Kawashima S, and Yokoyama M. Myristoylation of endothelial cell nitric oxide synthase is important for extracellular release of nitric oxide. Mol Cell Biochem 152: 143-148, 1995.
110. Salerno JC, Harris DE, Irizarry K, Patel B, Morales AJ, Smith SM, Martasek P, Roman LJ, Masters BS, Jones CL, Weissman BA, Lane P, Liu Q, and Gross SS. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem 272: 29769-29777, 1997.
111. Sanchez dM, Alonso J, Gonzalez-Fernandez F, de la Osada J, Monton M, Rodriguez-Feo JA, Guerra JI, Arriero MM, Rico L, Casado S, and Lopez-Farre A. Evidence that an endothelial cytosolic protein binds to the 3′-untranslated region of endothelial nitric oxide synthase mRNA. J Vasc Res 36: 201-208, 1999.
112. Sato S, Fujita N, and Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA 97: 10832-10837, 2000.
113. Schmidt K, Gibraeil HD, and Mayer B. Lack of involvement of extracellular signal-regulated kinase (ERK) in the agonist-induced endothelial nitric oxide synthesis. Biochem Pharmacol 63: 1137-1142, 2002.
114. Searles CD, Miwa Y, Harrison DG, and Ramasamy S. Posttranscriptional regulation of endothelial nitric oxide synthase during cell growth. Circ Res 85: 588-595, 1999.
115. Segal SS, Brett SE, and Sessa WC. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters. Am J Physiol Heart Circ Physiol 277: H1167-H1177, 1999.
116. Sessa WC, Barber CM, and Lynch KR. Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Circ Res 72: 921-924, 1993.
117. Sessa WC, García-Cardena G, Liu J, Keh A, Pollock JS, Bradley J, Thiru S, Braverman IM, and Desai KM. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem 270: 17641-17644, 1995.
118. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying YS, Anderson RGW, and Michel T. Acylation targets endothelial nitric oxide synthase to plasmalemmal caveolae. J Biol Chem 271: 6518-6522, 1996.
119. Simoncini T, Genazzani AR, and Liao JK. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation 105: 1368-1373, 2002.
120. 2+/calmodulin binding. Biochem J 355: 357-360, 2001.
121. Sowa G, Liu J, Papapetropoulos A, Rex-Haffner M, Hughes TE, and Sessa WC. Trafficking of endothleial nitric oxide synthase in living cells. J Biol Chem 274: 22524-22531, 1999.
122. Sumi D, Hayashi T, Jayachandran M, and Iguchi A. Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor alpha through estrogen receptor mediated system. Life Sci 69: 1651-1660, 2001.
123. Tang JL, Zembowicz A, Xu XM, and Wu KK. Role of Sp1 in transcriptional activation of human nitric oxide synthase type III gene. Biochem Biophys Res Commun 213: 673-680, 1995.
124. Teichert AM, Karantzoulis-Fegaras F, Wang Y, Mawji IA, Bei X, Gnanapandithen K, and Marsden PA. Characterization of the murine endothelial nitric oxide synthase promoter. Biochim Biophys Acta 1443: 352-357, 1998.
125. Teichert AM, Miller TL, Tai SC, Wang Y, Bei X, Robb GB, Phillips MJ, and Marsden PA. In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene. Am J Physiol Heart Circ Physiol 278: H1352-H1361, 2000.
126. Turi A, Kiss AL, and Mullner N. Estrogen downregulates the number of caveolae and the level of caveolin in uterine smooth muscle. Cell Biol Int 25: 785-794, 2001.
127. Venema RC, Nishida K, Alexander RW, Harrison DG, and Murphy TJ. Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochim Biophys Acta 1218: 413-420, 1994.
128. Venema RC, Sayegh HS, Kent JD, and Harrison DG. Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J Biol Chem 271: 6435-6440, 1996.
129. Venema VJ, Marrero MB, and Venema RC. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun 226: 703-710, 1996.
130. Wang X, Barber DA, Lewis DA, McGregor CG, Sieck GC, Fitzpatrick LA, and Miller VM. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells. Am J Physiol Heart Circ Physiol 273: H1962-H1967, 1997.
131. Wang XL and Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 70: 241-251, 2000.
132. Wariishi S, Miyahara K, Toda K, Ogoshi S, Doi Y, Ohnishi S, Mitsui Y, Yui Y, Kawai C, and Shizuta Y. A SP1 binding site in the GC-rich region is essential for a core promoter activity of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 216: 729-735, 1995.
133. Xu HL, Galea E, Santizo RA, Baughman VL, and Pelligrino DA. The key role of caveolin-1 in estrogen-mediated regulation of endothelial nitric oxide synthase function in cerebral arterioles in vivo. J Cereb Blood Flow Metab 21: 907-913, 2001.
134. Yang S, Bae L, and Zhang L. Estrogen increases eNOS and NOx release in human coronary artery endothelium. J Cardiovasc Pharmacol 36: 242-247, 2000.
135. Yoshizumi M, Perrella MA, Burnett JC Jr, and Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73: 205-209, 1993.
136. Zhang J, Patel JM, Li YD, and Block ER. Proinflammatory cytokines downregulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells. Res Commun Mol Pathol Pharmacol 96: 71-87, 1997.
137. Zhang R, Min W, and Sessa WC. Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem 270: 15320-15326, 1995.